Cardiff Oncology Reports Third Quarter 2025 Results and Provides Business Update

Cardiff Oncology Reports Third Quarter 2025 Results and Provides Business Update GlobeNewswire November 06, 2025 – Announced positive data from the ongoing Phase 2 CRDF-004 trial evaluating onvansertib + standard of care for the treatment of first-line RAS-mutated metastatic colorectal cancer – – Expects to report an update from the Phase 2 CRDF-004 trial in […]

Cytek Biosciences to Participate in Upcoming Investor Conferences

(NASDAQ:CTKB), FREMONT, Calif., Nov. 06, 2025 (GLOBE NEWSWIRE) — Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, today announced the company will be participating in the following investor conferences. UBS Global Healthcare Conference in Palm Beach, FLParticipating in investor 1×1 meetings on Tuesday, November 11, 2025 Stephens NASH25 Investment Conference in Nashville,

Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)

Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire November 06, 2025 CONSHOHOCKEN, Pa., Nov. 06, 2025 (GLOBE NEWSWIRE) — Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL), a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), today announced that it granted equity awards on November 1, 2025 to 18 new

Seer Reports Third Quarter 2025 Financial Results

Seer Reports Third Quarter 2025 Financial Results GlobeNewswire November 06, 2025 REDWOOD CITY, Calif., Nov. 06, 2025 (GLOBE NEWSWIRE) — Seer, Inc. (Nasdaq: SEER), the pioneer and trusted partner for deep, unbiased proteomic insights, today reported financial results for the third quarter ended September 30, 2025. Recent Highlights Generated revenue of $4.1 million for the

Barfresh Announces Third Quarter 2025 Results

Barfresh Announces Third Quarter 2025 Results GlobeNewswire November 06, 2025 Record Quarterly Revenue of $4.2 Million, an Increase of 16% Year-Over-Year for Third Quarter 2025 Achieved Positive Adjusted EBITDA and Gross Margin of 37% for Third Quarter 2025 Reiterates Fiscal 2025 Revenue Guidance to $14.5-$15.5 Million and Preliminary Fiscal 2026 Guidance of $30-$35 Million Completes

Robinhood Markets, Inc. to Present at the Wolfe Research Wealth Symposium on November 12, 2025

Robinhood Markets, Inc. to Present at the Wolfe Research Wealth Symposium on November 12, 2025 GlobeNewswire November 06, 2025 MENLO PARK, Calif., Nov. 06, 2025 (GLOBE NEWSWIRE) — Robinhood Markets, Inc. (“Robinhood”) (NASDAQ: HOOD) today announced that it will be participating in the upcoming Wolfe Research Wealth Symposium on Wednesday, November 12, 2025. Robinhood Chief

Nutanix Announces Date and Conference Call Information for First Quarter Fiscal Year 2026 Financial Results

Nutanix Announces Date and Conference Call Information for First Quarter Fiscal Year 2026 Financial Results GlobeNewswire November 06, 2025 SAN JOSE, Calif., Nov. 06, 2025 (GLOBE NEWSWIRE) — Nutanix, Inc. (NASDAQ: NTNX), a leader in hybrid multicloud computing, today announced that it will report its financial results for the first quarter of fiscal year 2026,

IBEX Reports Record Start to Fiscal 2026, Raises Full Year Guidance

IBEX Reports Record Start to Fiscal 2026, Raises Full Year Guidance GlobeNewswire November 06, 2025 Record first quarter Revenue, Adjusted EBITDA, EPS, Adjusted EPS, and Free Cash Flow Revenue grew 16.5% versus prior year quarter EPS grew 91% year-over-year to $0.82 and adjusted EPS grew 74% to $0.90 Raises Fiscal Year Guidance WASHINGTON, Nov. 06,

TTEC Announces Third Quarter 2025

TTEC Announces Third Quarter 2025 GlobeNewswire November 06, 2025 Third Quarter 2025 Revenue was $519.1 Million Net Loss was $11.1 Million or negative 2.1 Percent of Revenue(Net Income of $5.9 Million or 1.1 Percent of Revenue Non-GAAP) Adjusted EBITDA was $43.4 Million or 8.4 Percent of Revenue Reiterates Outlook for Full Year 2025Announces Term Extension

GrowGeneration Reports Third Quarter 2025 Financial Results

GrowGeneration Reports Third Quarter 2025 Financial Results GlobeNewswire November 06, 2025 Net Loss Improved by $9.0 million Year-Over-Year and Adjusted EBITDA turned positive at $1.3 Million Double-Digit Net Sales Growth of 15.4% Sequentially, Exceeding Guidance at $47.3 million Proprietary Brand Sales Drive Margin Expansion, Rising to 31.6% of Cultivation and Gardening Revenue from 23.8% in

Scroll to Top